Clinical Trial Update: Naltrexone for Relapse Prevention [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating naltrexone for relapse prevention in alcohol use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: UConn Health | Conditions: Alcoholism | Phase 4 | Status: COMPLETED